Skip to content

IKT - Inhibikase Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Inhibikase Therapeutics Inc

IKT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IKTInhibikase Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $2.53
52-wk low: $1.33
Prev close: $1.92
Mkt cap: $341.9M
Beta: 0.95
P/S: 10.4x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$31.4M

MI
Millennium
Israel Englander · Q2 2026 13F
$8.2M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $342M

Valuation

P/S10.39
P/B2.17

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IKT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $341.86M
Beta: 0.95

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.2x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-52.0%

$1.6M

position

AQ

AQR

Q2 2026 13F

$950K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for IKT

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

EPS expected

-$0.10

-$0.11 to -$0.09

Revenue expected

$0.00

6 analysts

Last 30 days

1up0down

Analysts raising estimates

Estimate drift

0.01

Change in 30 days

-52.0%

ROA-32.8%

Growth

Beta0.95